Nathalie is an expert in translational biomedical research for rare and neurological diseases with extensive experience in academia, biotech, and the pharmaceutical industry in Europe and in the USA. For the past several years, Nathalie has occupied top management positions in research-driven patient organizations including the Foundation for Prader-Willi Research, the French Association for Neuro-muscular disorders and the Amyotrophic Lateral Sclerosis Association where she developed and implemented strategies to accelerate the development of innovative therapies for rare and neurological diseases. She received her Ph.D in Neuroscience from the University Pierre and Marie Curie in Paris and did her postdoctoral training at the Salk Institute in La Jolla, CA.
